Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Neurology

Understanding Your Diagnostic Criteria and Lab Reports

At a Glance

POEMS syndrome is diagnosed by finding both polyneuropathy and a clonal plasma cell disorder, plus at least one other major feature and one minor feature. VEGF, nerve studies, imaging, and blood or bone marrow tests help confirm the diagnosis and rule out mimics.

A diagnosis of POEMS syndrome is not based on a single symptom or test result. Instead, doctors use a strict set of “criteria” to build a case. To be formally diagnosed, you must meet a specific combination of mandatory, major, and minor features [1][2]. However, clinical judgment is always required, and your doctor will also work to exclude other conditions that can mimic POEMS.

The Three-Tiered Diagnostic Framework

The most widely used guidelines require both mandatory criteria, plus at least one other major criterion and at least one minor criterion [2][3].

1. Mandatory Criteria (You must have both)

  • Polyneuropathy: This is damage to many nerves, typically causing weakness and numbness that begins in the feet and moves upward [4].
  • Clonal Plasma Cell Disorder: Evidence of a small population (a “clone”) of abnormal plasma cells. This is usually found via a bone marrow biopsy or by locating a localized bone lesion called a plasmacytoma [1].

2. Major Criteria (You must have at least one of these)

  • Sclerotic Bone Lesions: Abnormal areas of hardened, dense bone seen on X-rays, CT, or PET scans [5].
  • Elevated VEGF: High levels of Vascular Endothelial Growth Factor in your blood [6].
  • Castleman Disease: A rare disorder of the lymph nodes that sometimes occurs alongside POEMS [7].

3. Minor Criteria (You must have at least one of these)

  • Organomegaly: An enlarged liver, spleen, or lymph nodes [3].
  • Extravascular Volume Overload: Swelling (edema) in the legs, fluid in the abdomen (ascites), or fluid around the lungs [8].
  • Endocrinopathy: Abnormalities in hormone-producing glands (e.g., thyroid, adrenal, or reproductive glands) [3].
  • Skin Changes: Darkening, thickening, or small red spots (hemangiomas) [9].
  • Papilledema: Swelling of the optic nerve at the back of the eye, observed during an eye exam [10].
  • Thrombocytosis or Polycythemia: Having too many platelets or red blood cells [11].

Distinguishing POEMS from Similar Conditions

POEMS is frequently mistaken for CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy) because both involve damage to the nerve’s protective coating (demyelination). However, while CIDP primarily affects the nerves, POEMS is a multisystem disease [4]. Nerve conduction studies (NCS) in POEMS often show a distinct pattern—such as a higher degree of axonal loss (physical damage to the nerve fibers themselves) alongside demyelination, which helps specialists differentiate it from CIDP [12][13].

Understanding VEGF as a Biomarker

VEGF is a major criterion and an important contributor to POEMS symptoms, but it is not a perfect standalone test [14].

  • Sensitivity: While high VEGF is very common in untreated POEMS, a normal result does not automatically exclude the disease [15].
  • Limitations: VEGF levels depend heavily on the specific laboratory assay and whether serum or plasma is used. Other conditions, such as iron-deficiency anemia, lung disease (COPD), or even recent infections, can also raise VEGF [15][16].
  • Tracking: Doctors frequently use VEGF as a marker to monitor your response to treatment over time, always interpreting it alongside your physical symptoms [17].

Deciphering Your Workup and Lab Report

You may undergo several tests and see technical terms in your medical records. Here is a brief glossary:

  • SPEP / Immunofixation: Blood and urine tests used to detect the secreted Monoclonal protein (M-protein) produced by the abnormal plasma cells [18].
  • Bone Marrow Biopsy / Flow Cytometry: Tests to examine the cells inside your bone marrow to confirm the presence of the plasma cell clone [1].
  • Lambda-Restricted: The abnormal plasma cells in POEMS typically produce a specific type of light chain protein called “lambda” (rather than “kappa”) [19][20].
  • Sclerotic: Areas of bone that have become unusually thick or dense (the opposite of “lytic” or “punched-out” holes seen in multiple myeloma) [5][21].
  • Terminal Latency Index (TLI): A measurement from a nerve conduction study. A high TLI is one of several supportive patterns that a neurologist may use to distinguish POEMS from CIDP [12].
  • Echocardiogram: An ultrasound of the heart used to estimate pressures in the lungs and screen for pulmonary hypertension.

Common questions in this guide

What findings are needed to diagnose POEMS syndrome?
Doctors must find both polyneuropathy and a clonal plasma cell disorder. They also need at least one other major feature, such as a sclerotic bone lesion or high VEGF, and at least one minor feature, while excluding conditions that can look similar.
Does a normal VEGF level rule out POEMS syndrome?
No. VEGF is often high in untreated POEMS, but a normal result does not by itself exclude the disease. Doctors consider the sample type, laboratory method and range, symptoms, and other test results.
How can nerve testing tell POEMS apart from CIDP?
Both conditions can damage the nerve's protective coating, but POEMS affects multiple body systems. Nerve conduction studies in POEMS may show damage to the nerve fibers in addition to demyelination, and neurologists may use patterns such as a high terminal latency index when making the distinction.
What does lambda-restricted mean on a POEMS lab report?
It means the abnormal plasma cells are making one type of light-chain protein called lambda rather than kappa. This pattern is commonly associated with POEMS, but it is interpreted together with immunofixation, bone marrow findings, imaging, and the other diagnostic criteria.
Which tests look for the plasma cell disorder in POEMS?
SPEP and serum or urine immunofixation can look for the monoclonal protein made by abnormal plasma cells. A bone marrow biopsy and flow cytometry can examine marrow cells for the plasma cell clone, while imaging can evaluate for bone lesions.
What does a sclerotic bone lesion mean?
A sclerotic lesion is an area of unusually hard or dense bone seen on imaging. It differs from the punched-out, weakened areas called lytic lesions that are associated with multiple myeloma.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my lab work meet both mandatory criteria (polyneuropathy and clonal plasma cells), plus which specific major and minor criteria?
  2. 2.Was my VEGF test performed on serum or plasma, and how does my result compare to the laboratory's specific normal range for that test?
  3. 3.How does my nerve conduction study (NCS) help distinguish my condition from CIDP, specifically regarding signs of axonal damage?
  4. 4.Was my monoclonal protein (M-protein) detected through serum/urine immunofixation, and did you also perform a bone marrow biopsy with flow cytometry?
  5. 5.For the bone lesions found on my imaging, are they described as 'sclerotic,' and are they located in areas typical for POEMS?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.

    Dispenzieri A

    American journal of hematology 2019; (94(7)):812-827 doi:10.1002/ajh.25495.

    PMID: 31012139
  2. 2

    POEMS syndrome: update on diagnosis, risk-stratification, and management.

    Dispenzieri A

    American journal of hematology 2015; (90(10)):951-62 doi:10.1002/ajh.24171.

    PMID: 26331353
  3. 3

    Atypical polyneuropathy, organomegaly, endocrinopathy, monoclonal protein, and skin changes syndrome without polyneuropathy: A case report.

    Li Q, Xu F, Duan JF, Tang YF

    Medicine 2020; (99(27)):e20812 doi:10.1097/MD.0000000000020812.

    PMID: 32629667
  4. 4

    Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.

    Keddie S, Foldes D, Caimari F, et al.

    Neurology 2020; (95(3)):e268-e279 doi:10.1212/WNL.0000000000009940.

    PMID: 32606227
  5. 5

    Osteolytic-variant POEMS syndrome: an uncommon presentation of "osteosclerotic" myeloma.

    Clark MS, Howe BM, Glazebrook KN, et al.

    Skeletal radiology 2017; (46(6)):817-823 doi:10.1007/s00256-017-2607-8.

    PMID: 28343327
  6. 6

    POEMS syndrome: A multisystem clonal disorder.

    Ali T, Qazilbash MH

    European journal of haematology 2021; (106(1)):14-18 doi:10.1111/ejh.13514.

    PMID: 32889731
  7. 7

    Clinical spectrum of Castleman disease-associated neuropathy.

    Naddaf E, Dispenzieri A, Mandrekar J, Mauermann ML

    Neurology 2016; (87(23)):2457-2462 doi:10.1212/WNL.0000000000003405.

    PMID: 27807187
  8. 8

    Proposal of new clinical diagnostic criteria for POEMS syndrome.

    Suichi T, Misawa S, Sato Y, et al.

    Journal of neurology, neurosurgery, and psychiatry 2019; (90(2)):133-137 doi:10.1136/jnnp-2018-318514.

    PMID: 30279213
  9. 9

    POEMS Syndrome: an Enigma.

    Warsame R, Yanamandra U, Kapoor P

    Current hematologic malignancy reports 2017; (12(2)):85-95 doi:10.1007/s11899-017-0367-0.

    PMID: 28299525
  10. 10

    Peripheral retinal leakage in POEMS syndrome.

    Carey AR, Jeyaseelan P

    International journal of retina and vitreous 2021; (7(1)):6 doi:10.1186/s40942-020-00278-1.

    PMID: 33436019
  11. 11

    Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy.

    Naddaf E, Dispenzieri A, Mandrekar J, Mauermann ML

    Muscle & nerve 2015; (52(4)):658-9 doi:10.1002/mus.24768.

    PMID: 26179010
  12. 12

    Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome.

    Wang Q, Liu P, Ji LL, et al.

    Chinese medical journal 2019; (132(14)):1666-1672 doi:10.1097/CM9.0000000000000318.

    PMID: 31268911
  13. 13

    Neurological Peculiarities of POEMS Syndrome: Experience From a Brazilian University Center.

    Rosenstein RF, Soares Baima JP, Meneguin Pereira TD, et al.

    Muscle & nerve 2026; (73(3)):421-426 doi:10.1002/mus.70114.

    PMID: 41408967
  14. 14

    [Recent advances in pathogenesis, diagnosis, and therapeutic strategies for POEMS syndrome].

    Tsukamoto S

    [Rinsho ketsueki] The Japanese journal of clinical hematology 2026; (67(5)):453-461 doi:10.11406/rinketsu.67.453.

    PMID: 42236249
  15. 15

    Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome.

    Pihan M, Keddie S, D'Sa S, et al.

    Neurology(R) neuroimmunology & neuroinflammation 2018; (5(5)):e486 doi:10.1212/NXI.0000000000000486.

    PMID: 30175160
  16. 16

    Dramatically elevated plasma vascular endothelial growth factor levels from influenza A infection in polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome: A case report.

    Kannan A, Zhuo Y, Banerjee R

    EJHaem 2024; (5(4)):842-844 doi:10.1002/jha2.965.

    PMID: 39157604
  17. 17

    Requirement of Repeated Serum VEGF Measurements in POEMS Syndrome.

    Nomura T, Iwata I, Eguchi K, et al.

    Internal medicine (Tokyo, Japan) 2025; (64(5)):769-773 doi:10.2169/internalmedicine.4086-24.

    PMID: 39085069
  18. 18

    Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry.

    Ishii A, Tsukamoto S, Mimura N, et al.

    Scientific reports 2024; (14(1)):10362 doi:10.1038/s41598-024-61034-1.

    PMID: 38710832
  19. 19

    Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome.

    Kawajiri-Manako C, Mimura N, Fukuyo M, et al.

    American journal of hematology 2018; (93(9)):1161-1168 doi:10.1002/ajh.25213.

    PMID: 30015379
  20. 20

    Atypical Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, and Skin Changes (POEMS) Syndrome.

    Bishara M, Homeniuk A, Patel A, et al.

    Cureus 2026; (18(2)):e103791 doi:10.7759/cureus.103791.

    PMID: 41869173
  21. 21

    Bone lesions in Chinese POEMS syndrome patients: imaging characteristics and clinical implications.

    Wang F, Huang X, Zhang Y, et al.

    PeerJ 2016; (4()):e2294 doi:10.7717/peerj.2294.

    PMID: 27547585

This page explains POEMS syndrome diagnostic criteria and lab-report terms for informational purposes only; it does not constitute medical advice. Your hematologist, neurologist, and other specialists should interpret your results in context.

Get notified when new evidence is published on POEMS syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.